Mumbai: The CBI told Wednesday the Bombay High Court that Rhea Chakraborty’s accusation that late actor Sushant Singh Rajput’s sisters obtained a fake medical prescription for him was ‘mostly speculative’. Such speculation by Rhea Chakraborty cannot be the basis of an FIR, the Central agency said. The agency was speaking in response to Rajput’s sisters Priyanka Singh and Meetu Singh’s petition. It is seeking to quash the case lodged against them by Mumbai Police.
Rhea has alleged that a fabricated prescription was used to help him procure medicines. These medicines were banned under the Narcotic Drugs and Psychotropic Substances Act. The fabricated prescription was used only a few days before his suicide June 14.
“The allegations in the present FIR are mostly presumptive and speculative in nature,” the CBI said.
Rajput’s sisters filed the petition October 6 through advocate Madhav Thorat. They sought that the FIR filed against them by Bandra Police here be quashed. The CBI said the police should have conducted preliminary enquiry before registering the FIR.
“It is settled law that two FIRs cannot be registered on the same cause of action. The CBI is already investigating the causes relating to the death of Sushant Singh Rajput and all aspects surrounding the same. In view of this, it was expected from the Mumbai police to forward the complaint received from Rhea Chakraborty to the CBI instead of registering FIR itself,” the CBI said.
“Therefore, registration of FIR on the same facts and cause of action is both unwarranted and not allowed under law. Thus, this FIR is vitiated and bad in law,” the agency added.
If Rhea Chakraborty was aware of the mobile phone chat between Rajput and his sister Priyanka in June 2020 during which Priyanka allegedly sent him a medical prescription, then Rhea should not have kept silent till September, the CBI said.
The police’s FIR names Rajput’s two sisters and a doctor of the Ram Manohar Lohia Hospital in Delhi, Tarun Kumar. It was he who allegedly signed the medical prescription.
The HC will hear the petition again November 4.